The origin of circulating 13,14-dihydro-15-keto-prostaglandin F2 alpha during delivery.
All uterine tissues as well as the fetal membranes and the placenta can form prostaglandins from endogenous precursors in vitro but it is not clear which of the tissues is the main site for the increase in PGF2 alpha production during human parturition. To examine this question, we measured plasma prostaglandin levels before and at intervals after expulsion of the fetus, placenta, and membranes. The concentration of PGFM at the beginning of the second stage of labor was significantly higher than before the onset of labor. Five minutes after the birth of the infant, the concentration had doubled. Thirty minutes after the expulsion of placenta and membranes, plasma PGFM had fallen to the levels at full dilatation; two hours postpartum it was still significantly raised over levels before labor. Since the halflife of PGFM in the circulation is about 7 minutes, these findings indicate that the uterine tissues are important sources of PGFM during labor. In contrast, endogenous oxytocin levels, which were significantly raised over control levels at the second stage of labor, did not change during the third stage, and declined postpartum to control levels. Oxytocin infusion did not influence PGFM levels at 5 and at 30 minutes postpartum, but raised them at 2 hours.
D000328:Adult; D015237:Dinoprost / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D007700:Kinetics; D007743:Labor, Obstetric; D010121:Oxytocin / Q000097:blood / Q000494:pharmacology; D011247:Pregnancy; D011460:Prostaglandins F / Q000097:blood*; D014599:Uterus / Q000378:metabolism
D011460:Prostaglandins F; C008228:15-keto-13,14-dihydroprostaglandin F2alpha; D010121:Oxytocin; D015237:Dinoprost